Filing Details

Accession Number:
0001209191-23-047514
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-28 16:20:16
Reporting Period:
2023-08-24
Accepted Time:
2023-08-28 16:20:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1672619 Enliven Therapeutics Inc. ELVN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598549 J. Andrew Schwab C/O 5Am Venture Management, Llc
501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1664281 Kush Parmar C/O 5Am Venture Management, Llc
501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1753000 5Am Opportunities I, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1753037 5Am Ventures Vi, L.p. 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1790778 5Am Opportunities I (Gp), Llc 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
1829051 5Am Partners Vi, Llc 501 2Nd Street, Suite 350
San Francisco CA 94107
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-08-24 367,124 $16.00 4,470,968 No 4 S Indirect By 5AM Ventures VI, L.P.
Common Stock Disposition 2023-08-24 72,876 $16.00 887,507 No 4 S Indirect By 5AM Opportunities I, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By 5AM Ventures VI, L.P.
No 4 S Indirect By 5AM Opportunities I, L.P.
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
  3. The shares are directly held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein.